RJA
AMGN icon

Ross\Johnson & Associates’s Amgen AMGN Stock Holding History

Ross\Johnson & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Hold
300
– – 1.7% 11
2026
Q1 		$106K Sell
300
-1
-0.3% -$356 1.9% 8
2025
Q4 		$98.5K Buy
301
+1
+0.3% +$317 1.83% 13
2025
Q3 		$84.7K Hold
300
– – 1.6% 12
2025
Q2 		$83.8K Hold
300
– – 1.72% 10
2025
Q1 		$93.5K Hold
300
– – 1.6% 9
2024
Q4 		$78.2K Buy
+300
New +$89K 1.81% 6

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ross\Johnson & Associates's AMGN Position: Q2 2026 in Review

Ross\Johnson & Associates held its Amgen (AMGN) position steady in Q2 2026 at 300 shares worth $109K. The position accounts for 1.7% of the portfolio, ranked #11.

Ross\Johnson & Associates first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ross\Johnson & Associates held 300 shares of Amgen worth $109K as of Q2 2026.
  • Ross\Johnson & Associates left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 1.7% of Ross\Johnson & Associates's portfolio in Q2 2026, its #11 holding.
  • Ross\Johnson & Associates first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.